drugset / Trial / NCT05794165
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
Phase 2
Enrolling by invitation
314 enrolled
Bryan Cotton
Grifols Shared Services North America, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if additional interventions will assist with decreasing the risk and/or severity of thromboembolism (clotting complications) in patients who have experienced a major traumatic event.
Timeline
- Start
- 2023-09-27
- Primary completion
- 2026-11
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Antithrombin III | Protein / enzyme biologic | — | Intravenous |